John Bunni1, David Arnold2, Golda Shelley-Fraser3, Jamshed Shabbir2. 1. Department of Colorectal Surgery, Bristol Royal Infirmary, Bristol, United Kingdom. Electronic address: johnbunni@hotmail.com. 2. Department of Colorectal Surgery, Bristol Royal Infirmary, Bristol, United Kingdom. 3. Department of Pathology, Bristol Royal Infirmary, Bristol, United Kingdom.
Abstract
BACKGROUND: Adenocarcinoma of the vermiform appendix is rare. It constitutes less than 0.5% of all gastrointestinal malignancies. Pathologically, appendiceal neoplasms are categorized into various subtypes depending on cell lineage. PATIENTS AND METHODS: We considered a case series of appendiceal invasive adenocarcinomas from 2004 to 2013 managed in a teaching hospital. We discuss our management dilemmas, given the lack of randomized controlled trial data that exist. A detailed look at the histopathology, case series, and literature is presented. RESULTS: Ideal standards ought to be constructed for the management of this rare pathology, with a particular focus on exploring the indications and potential benefits, as well as difficulties, of ileocolic lymphadenectomy. CONCLUSION: Appendiceal adenocarcinoma ought to be managed in the same way as a cecal adenocarcinoma.
BACKGROUND:Adenocarcinoma of the vermiform appendix is rare. It constitutes less than 0.5% of all gastrointestinal malignancies. Pathologically, appendiceal neoplasms are categorized into various subtypes depending on cell lineage. PATIENTS AND METHODS: We considered a case series of appendiceal invasive adenocarcinomas from 2004 to 2013 managed in a teaching hospital. We discuss our management dilemmas, given the lack of randomized controlled trial data that exist. A detailed look at the histopathology, case series, and literature is presented. RESULTS: Ideal standards ought to be constructed for the management of this rare pathology, with a particular focus on exploring the indications and potential benefits, as well as difficulties, of ileocolic lymphadenectomy. CONCLUSION:Appendiceal adenocarcinoma ought to be managed in the same way as a cecal adenocarcinoma.